HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hirohisa Nose Selected Research

Therapeutics

9/2006Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial.
7/2006Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hirohisa Nose Research Topics

Disease

4Tropical Spastic Paraparesis (Tropical Spastic Paraplegia)
12/2007 - 10/2005
3Spinal Cord Diseases
12/2007 - 10/2005
2Infections
12/2007 - 09/2006
1Inclusion Body Myositis
01/2008
1Disease Susceptibility (Diathesis)
12/2007

Drug/Important Bio-Agent (IBA)

1HTLV-I AntibodiesIBA
01/2008
1HLA-DRB1 Chains (HLA DRB1)IBA
12/2007
1Peptides (Polypeptides)IBA
12/2007
1Complementarity Determining Regions (Complementarity Determining Region)IBA
12/2007
1Zidovudine (Retrovir)FDA LinkGeneric
09/2006
1NucleosidesIBA
09/2006
1Lamivudine (Epivir)FDA Link
09/2006
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
07/2006
1Interferon-alpha (Interferon Alfa)IBA
07/2006

Therapy/Procedure

2Therapeutics
09/2006 - 07/2006
1Oral Administration
10/2005